LLtech

LLTech is a medical technology company specializing in high-resolution, non-destructive tissue imaging for clinical and research applications. The company utilizes proprietary Full-field Optical Coherence Tomography (FF-OCT) technology to provide cellular-level visualization of fresh tissue biopsies in real-time. Its flagship product, the Light-CT Scanner, enables surgeons and pathologists to perform rapid assessment of tumor margins and tissue morphology without the need for traditional staining or chemical processing. This technology is particularly valuable in oncology for procedures such as breast-conserving surgery and prostate biopsies, where immediate feedback can improve surgical outcomes. By digitizing the pathology workflow at the point of care, LLTech aims to reduce the rate of secondary surgeries and streamline diagnostic decision-making. Headquartered in France, the company was acquired by Excilone in 2021 to integrate its imaging capabilities into a broader digital pathology portfolio.